283 related articles for article (PubMed ID: 20923924)
1. A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality.
Bradley AJ; Dinan TG
J Psychopharmacol; 2010 Nov; 24(4 Suppl):91-118. PubMed ID: 20923924
[TBL] [Abstract][Full Text] [Related]
2. [Stress and psychotic transition: A literature review].
Chaumette B; Kebir O; Mam Lam Fook C; Bourgin J; Godsil BP; Gaillard R; Jay TM; Krebs MO
Encephale; 2016 Aug; 42(4):367-73. PubMed ID: 27161263
[TBL] [Abstract][Full Text] [Related]
3. Stress and the hypothalamic pituitary adrenal axis in the developmental course of schizophrenia.
Walker E; Mittal V; Tessner K
Annu Rev Clin Psychol; 2008; 4():189-216. PubMed ID: 18370616
[TBL] [Abstract][Full Text] [Related]
4. The hypothalamo-pituitary-adrenal axis in major affective disorder: a review.
Christensen MV; Kessing LV
Nord J Psychiatry; 2001; 55(5):359-63. PubMed ID: 11839128
[TBL] [Abstract][Full Text] [Related]
5. Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders.
Phillips LJ; McGorry PD; Garner B; Thompson KN; Pantelis C; Wood SJ; Berger G
Aust N Z J Psychiatry; 2006 Sep; 40(9):725-41. PubMed ID: 16911747
[TBL] [Abstract][Full Text] [Related]
6. Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis.
Soria V; González-Rodríguez A; Huerta-Ramos E; Usall J; Cobo J; Bioque M; Barbero JD; García-Rizo C; Tost M; Monreal JA; ; Labad J
Psychoneuroendocrinology; 2018 Jul; 93():8-19. PubMed ID: 29680774
[TBL] [Abstract][Full Text] [Related]
7. Sympathetic and hypothalamic-pituitary-adrenal asymmetry in generalized anxiety disorder.
Reeves JW; Fisher AJ; Newman MG; Granger DA
Psychophysiology; 2016 Jun; 53(6):951-7. PubMed ID: 26934635
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic-pituitary-adrenal axis function in chronic schizophrenia: association with clinical features.
Kaneko M; Yokoyama F; Hoshino Y; Takahagi K; Murata S; Watanabe M; Kumashiro H
Neuropsychobiology; 1992; 25(1):1-7. PubMed ID: 1351264
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities in metabolism and hypothalamic-pituitary-adrenal axis function in schizophrenia.
Guest PC; Martins-de-Souza D; Vanattou-Saifoudine N; Harris LW; Bahn S
Int Rev Neurobiol; 2011; 101():145-68. PubMed ID: 22050851
[TBL] [Abstract][Full Text] [Related]
10. A.E. Bennett award paper. Experimental approaches to human stress research: assessment of neurobiological mechanisms of stress in volunteers and psychiatric patients.
Breier A
Biol Psychiatry; 1989 Sep; 26(5):438-62. PubMed ID: 2551397
[TBL] [Abstract][Full Text] [Related]
11. Alterations in HPA-axis and autonomic nervous system functioning in childhood anxiety disorders point to a chronic stress hypothesis.
Dieleman GC; Huizink AC; Tulen JH; Utens EM; Creemers HE; van der Ende J; Verhulst FC
Psychoneuroendocrinology; 2015 Jan; 51():135-50. PubMed ID: 25305548
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic-pituitary-adrenal axis in schizophrenia.
Altamura AC
Biol Psychiatry; 1996 Sep; 40(6):560-1. PubMed ID: 8879482
[No Abstract] [Full Text] [Related]
13. The stress cascade and schizophrenia: etiology and onset.
Corcoran C; Walker E; Huot R; Mittal V; Tessner K; Kestler L; Malaspina D
Schizophr Bull; 2003; 29(4):671-92. PubMed ID: 14989406
[TBL] [Abstract][Full Text] [Related]
14. Endogenous opioid regulation of hypothalamo-pituitary-adrenal axis activity in schizophrenia.
Wolkowitz OM; Doran AR; Breier A; Cohen MR; Pickar D
Biol Psychiatry; 1986 Apr; 21(4):366-73. PubMed ID: 2869791
[TBL] [Abstract][Full Text] [Related]
15. Dimensions of depression and anxiety and the hypothalamo-pituitary-adrenal axis.
Wardenaar KJ; Vreeburg SA; van Veen T; Giltay EJ; Veen G; Penninx BW; Zitman FG
Biol Psychiatry; 2011 Feb; 69(4):366-73. PubMed ID: 21030010
[TBL] [Abstract][Full Text] [Related]
16. Stress and HPA-axis functioning in young people at ultra high risk for psychosis.
Thompson KN; Phillips LJ; Komesaroff P; Yuen HP; Wood SJ; Pantelis C; Velakoulis D; Yung AR; McGorry PD
J Psychiatr Res; 2007 Oct; 41(7):561-9. PubMed ID: 16831447
[TBL] [Abstract][Full Text] [Related]
17. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress.
Smith SM; Vale WW
Dialogues Clin Neurosci; 2006; 8(4):383-95. PubMed ID: 17290797
[TBL] [Abstract][Full Text] [Related]
18. Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms.
Pivac N; Mück-Seler D; Jakovljević M
Neuropsychobiology; 1997; 36(1):19-21. PubMed ID: 9211439
[TBL] [Abstract][Full Text] [Related]
19. Mifepristone as a therapeutic agent in psychiatry.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2013 Jun; 51(6):11-4. PubMed ID: 23814820
[TBL] [Abstract][Full Text] [Related]
20. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities.
Licht CM; Vreeburg SA; van Reedt Dortland AK; Giltay EJ; Hoogendijk WJ; DeRijk RH; Vogelzangs N; Zitman FG; de Geus EJ; Penninx BW
J Clin Endocrinol Metab; 2010 May; 95(5):2458-66. PubMed ID: 20237163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
